Cooley (UK) LLP

Cooley (UK) LLP’s ‘exceptional’ life sciences practice is a go-to for clients seeking advice on complex transactions and financing. Recognised for its cross-practice strength, the team draws on healthcare regulatory, IP, data privacy, antitrust, and tax specialists to support life sciences deals. The practice is led by Simon Amies, who advises companies and investors on cross-border M&A, IPOs, capital markets offerings, and VC financings. Frances Stocks Allen handles a range of cross-border transactions, including AI and data-heavy deals, while the ’superb’ Tom Goodman is recognised for his transactional and corporate advice to emerging life sciences and biotechnology companies. Russell Anderson, promoted to partner in January 2025, advises on M&A and VC transactions, while Jenny Davies, who joined from Gowling WLG in the same month, brings expertise in licensing and collaboration deals, as well as patent counselling and prosecution. Nicola Maguire and John Wilkinson are no longer at the firm.